Aminoindan derivatives

Details Aminoindan derivatives Aminoindan derivatives

2007-05-08

2007-05-08

Barts, Samuel (Department: 1621)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

N-c doai

C514S481000, C560S029000, C560S032000, C560S115000, C560S136000

Reissue Patent

active

11091008

ABSTRACT:
This invention is directed to compounds of the following formula:wherein when a is 0, b is 1 or 2; when a is 1, b is 1, m is from 0-3, X is O or S, Y is halogeno, R1is hydrogen C1-4alkyl, R2is hydrogen, C1-4alkyl, or optionally substituted propargyl and R3and R4are each independently hydrogen, C1-6alkyl, C6-12aryl, C6-12aralkyl each optionally substituted.This invention is also directed to the use of these compounds for treating depression, Attention Deficit Disorder (ADD), Attention Deficit and Hyperactivity Disorder (ADHD), Tourette's Syndrome, Alzheimer's Disease and other dementia's such as senile dementia, dementia of the Parkinson's type, vascular dementia and Lewy body dementia.This invention is further directed to a pharmaceutical composition comprising a therapeutically effective amount of the above-defined compounds and a pharmaceutically acceptable carrier.

REFERENCES:
patent: 2573645 (1951-10-01), Kerwin et al.
patent: 2916490 (1959-12-01), Schenck et al.
patent: 2982783 (1961-05-01), Schenck et al.
patent: 3060091 (1962-10-01), Witkin
patent: 3123642 (1964-03-01), Temple et al.
patent: 3178478 (1965-04-01), Huebner et al.
patent: 3201470 (1965-08-01), Huebner et al.
patent: 3253037 (1966-05-01), Huebner et al.
patent: 3308157 (1967-03-01), Robertson et al.
patent: 3507962 (1970-04-01), Taylor
patent: 3513240 (1970-05-01), Bernardus et al.
patent: 3513244 (1970-05-01), Gittos et al.
patent: 3637740 (1972-01-01), Sarges
patent: 3704323 (1972-11-01), Krapcho
patent: 3709996 (1973-01-01), Gittos et al.
patent: 3751420 (1973-08-01), Hauck et al.
patent: 3804898 (1974-04-01), Panneman
patent: 3886168 (1975-05-01), Himmele et al.
patent: 3991207 (1976-11-01), Sarges et al.
patent: 4029731 (1977-06-01), Sarges
patent: 4096173 (1978-06-01), Molloy
patent: 4128666 (1978-12-01), Bondinell et al.
patent: 4132737 (1979-01-01), Molloy
patent: 4134997 (1979-01-01), Cannon et al.
patent: 4172093 (1979-10-01), Göransson-Dahlander et al.
patent: 4632939 (1986-12-01), Beedle et al.
patent: 4638001 (1987-01-01), Kuhla et al.
patent: 4788130 (1988-11-01), Oshiro et al.
patent: 4792628 (1988-12-01), Oshiro et al.
patent: 4826875 (1989-05-01), Chiesi
patent: 4833273 (1989-05-01), Goel et al.
patent: 4873241 (1989-10-01), Napier et al.
patent: 4948807 (1990-08-01), Rosin et al.
patent: 5011995 (1991-04-01), Pugin et al.
patent: 5071875 (1991-12-01), Horn et al.
patent: 5118704 (1992-06-01), Minaskanian et al.
patent: 5134147 (1992-07-01), Peglion et al.
patent: 5153225 (1992-10-01), Schohe et al.
patent: 5189045 (1993-02-01), Peglion et al.
patent: 5196583 (1993-03-01), Yamada et al.
patent: 5225596 (1993-07-01), Carlsson et al.
patent: 5242919 (1993-09-01), Oshiro et al.
patent: 5273974 (1993-12-01), Goto et al.
patent: 5286747 (1994-02-01), Arvidsson et al.
patent: 5378729 (1995-01-01), Kohn et al.
patent: 5387612 (1995-02-01), Youdim et al.
patent: 5389687 (1995-02-01), Schaus et al.
patent: 5401758 (1995-03-01), Atwal et al.
patent: 5453446 (1995-09-01), Youdim et al.
patent: 5457133 (1995-10-01), Youdim et al.
patent: 5486541 (1996-01-01), Sterling et al.
patent: 5516943 (1996-05-01), Gao et al.
patent: 5519061 (1996-05-01), Youdim et al.
patent: 5532415 (1996-07-01), Youdim et al.
patent: 5569669 (1996-10-01), Guillaumet et al.
patent: 5576353 (1996-11-01), Youdim et al.
patent: 5602176 (1997-02-01), Enz
patent: 5646188 (1997-07-01), Gilad et al.
patent: 5654301 (1997-08-01), Kohn et al.
patent: 5708018 (1998-01-01), Haadsma-Svensson et al.
patent: 5877218 (1999-03-01), Herzig et al.
patent: 5914349 (1999-06-01), Cohen et al.
patent: 6251938 (2001-06-01), Chorev et al.
patent: 6303650 (2001-10-01), Chorev et al.
patent: 6462222 (2002-10-01), Chorev et al.
patent: 2004/0010038 (2004-01-01), Blaugrund et al.
patent: 0436492 (1991-10-01), None
patent: 0664291 (1993-10-01), None
patent: 0614888 (1994-02-01), None
patent: 0538134 (1997-03-01), None
patent: 0852735 (1960-11-01), None
patent: 1003686 (1965-09-01), None
patent: 3002155 (1991-03-01), None
patent: WO9100724 (1991-01-01), None
patent: WO9504027 (1995-02-01), None
patent: WO9511016 (1995-04-01), None
patent: WO9518617 (1995-07-01), None
patent: WO9602524 (1996-02-01), None
Armstrong et al., “Acylation Effects on Chiral Recognition of Racemic Amines and Alcohols by New Polar and Non-Polar Cyclodextrin Derivative Gas Chromatographic Phases”,J. Chromatography(1990) 502: 154-159.
Askin et al., “Highly Diastereoselective Alkylations of Chiral Amide Enolates: New Routes to Hydroxyethylene Dipeptide Isostere Inhibitors of HIV-1 Protease”,J. Org. Chem. (1992) 57(10): 2771-2773.
Baker et al., “Synthesis of Decahydrocyclopentacyclo-octene Derivatives via Intramolecular Photocycloaddition of Butenolides and Reductive Cleavage”,J. Chem. Soc. Chem. Comm. (1980) 23: 1011-1012.
Barton et al., “Reductive Formylation of Oximes; An Approach to the Synthesis of Vinyl Isonitriles”,Tetrahedron Letters(1988) 29(27): 3343-3346.
Boar et al., “A Simple Synthesis of Enamides from Ketoximes”,J. Chem. Soc. Perkins I(1975) 1237-1241.
Brettle et al., “Synthesis of Enamides”,J. Chem. Soc. Perkin Trans. I, (1988) 2185-2193.
Burk et al., “A Three-Step Procedure for Asymmetric Catalytic Reductive Amidation of Ketones”,J. Org. Chem. (1998) 63: 6084-6085.
Chorvat el al., “Acetycholine Release Enhancing Agents: Potential Therapeutics For Alzheimer's Disease”,Drugs of the Future(1995) 20(11):1145-1162.
Cooper et al., “Alzheimer's Disease Drug Treatment”,J. Ger. Drug Ther., (1993) 8(2):5-18.
Cutler et al., “Muscarinic M1-Receptor Agonists”,CNS Drugs(1995) 3(6):467-481.
Davis et al., “Tacrine”,The Lancet(1995) 345:625-630.
Drefahl et al., “Amino Alcohols. I. Cis- and Trans-DL-1-amino-2-hydroxytetrahydronaphthalene and Cis- and Trans-DL-1-amino-2-hydroxyindan”,Chem. Abstracts(1958) 52: 16417f.
Drefahl et al., “Amino Alcohols. X. Addition of Iodine Isocyanate to Unsymmetrical Olefins”,Chem. Abstracts(1960) 54: 13078f.
Finberg and Youdim, “Modification of Blood Pressure and Nictitating Membrane Response to Sympathetic Amines by Selective Monoamine Oxidase Inhibitors, Types A and B, in the Cat”,Brit. J. Pharmacol. (1985) 85(2): 541-546.
Fink et al., “Imino 1,2,3,4-Tetrahydrocyclopent[B]indole Carbamates as Dual Inhibitors of Acetylcholinesterase and Monoamine Oxidase”,Bioorganic&Medicinal Chemistry Letters(1996) 6(6): 625-630.
Fuller et al., “Inhibition in vitro of Norepinephrine N-methyltransferase by 2-Aminotetralins, Analogs of Phenylethylamines with Rigid Conformation”,Biochem. Pharmacol., (1976) 26: 446-447.
Gabryel et al., “Nootropics: Pharmacological Properties and Therapeutic Use”,Pol. J. Pharmacol. (1994) 46:383-394.
Ghislandi et al., “Scissione Ottica E Configurazione Dell'1-Aminobenzociclobutene E Dell'1-Aminoindano”,Boll. Chim. Farm. (1976) 115: 489-500.
Harvey, “The Pharmacology of Galanthamine and its Analogues”,Pharmac. Ther. (1995) 68(1):113-128.
Heikkila et al., “Prevention of MPTP-Induced Neurotoxicity by AGN-1133 and AGN-1135, Selective Inhibitors of Monoamine Oxidase-B”,Eur. J. Pharmacol. (1985) 116: 313-317.
Hori et al., “N-containing Diphenylethylamine Derivatives and Acid Adducts”, Japan Kokai Tokyo Koho JP 54-132559, Oct. 15, 1979, Database CAPLUS on STN®,Chemical Abstracts Service, (Columbus, Ohio), Accession No. 1980:180807, abstract.
Horn et al., “Steric Requirements for Catecholamine Uptake by Rat Brain Synaptosomes: Studies with Rigid Analogs of Amphetamine”,J. Pharmacol. Exp. Ther. (1972) 180: 523-530.
Huebner, “1-(N-Methyl-N-propargylamino)indans and Related Compounds”,Chem. Abstracts(1964) 61:3046a.
Kabins et al., “Potential Applications for Monoamine Oxidase B Inhibitors”,Dementia(1990) 1: 323-348.
Kametani et al., “Studies on the Syntheses of Heterocyclic Compounds. CLIX. The Reaction

Affiliated with

Also associated with

Rating

Aminoindan derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Aminoindan derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Aminoindan derivatives will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3818706